Validating Antibodies for Better Science and Better Medicine
Wednesday, May 24, 2023
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Introduction
Today's Presenters
Our Brands Support Your Entire R&D Pipeline
Bethyl: Making (and validating) your antibodies for over 50 years
The Reproducibility Crisis: Are Antibodies the Problem?
Impact of Poorly Characterized Antibodies
What does “validation” really mean?
A Structured Approach to Antibody Validation
The Bethyl Approach to Antibody Validation
Pillar 1: Independent Antibodies
Pillar 2: Complementary Assays
Pillar 3: Orthogonal Characteristics
Pillar 4: Biological Characteristics
Pillar 5: Recombinant Expression Strategies
Pillar 6: Genetic Strategies
What does this mean for you?
The Validation Gradient: Ideal to Useful
Challenge: Molecular Weight ≠ Predicted Molecular Weight
Challenge: Ubiquitous Expression and Localization
Challenge: Cell-Specific Isoforms
Antibody Validation vs Application Validation
Application Validation
We are all responsible for validating our antibodies
Evaluating Antibodies in the Market
Thank You!
Q1: What can I do if I purchase an antibody but it doesn’t work in the application it’s supposed to?
Q2: Can you explain more about your strategy for incorporating negative controls into your validation assays?
Q3: How do I know if an antibody will work in an application that isn’t listed in the product specs?
No transcript for this webinar
More Information
Request info